Evaluate Agilent's (A) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
A posts Q1 revenue growth and beats sales estimates, but margin pressure and earnings miss send shares lower in pre-market trade.
Agilent Technologies, Inc. (A) Q1 2026 Earnings Call Transcript
While the top- and bottom-line numbers for Agilent (A) give a sense of how the business performed in the quarter ended January 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Agilent Technologies (A) came out with quarterly earnings of $1.36 per share, missing the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $1.31 per share a year ago.
Life sciences firm Agilent Technologies on Wednesday reported first-quarter results that were largely in line with Wall Street estimates on stable demand for its medical tools and equipment used in lab research and diagnostic services.
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #CustomerFirst--Agilent Technologies, Inc. (NYSE: A) today reported revenue of $1.80 billion for the first quarter ended Jan. 31, 2026, representing growth of 7.0% reported and up 4.4% core(1) compared with the first quarter of 2025. First-quarter GAAP net income was $305 million, or $1.07 per share. This compares with $318 million, or $1.11 per share, in the first quarter of 2025. Non-GAAP(2) net income was $386 million, or $1.36 per share, during the quarter, compared wi.
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today announced that Chief Financial Officer Adam Elinoff and Head of Investor Relations Tejas Savant will participate in a fireside chat at TD Cowen's 46th Annual Health Care Conference. The event is scheduled for 11:10 to 11:40 a.m. EST on Tuesday, March 3, 2026, in Boston, Massachusetts. A live audio webcast and replay of the presentation will be available through Agilent's Investor Relations website. About Agilent Tec.
CenterBook Partners LP acquired a new position in shares of Agilent Technologies, Inc. (NYSE: A) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 10,386 shares of the medical research company's stock, valued at approximately $1,333,000. Other institutional investors and hedge funds
Get a deeper insight into the potential performance of Agilent (A) for the quarter ended January 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Assetmark Inc. increased its position in Agilent Technologies, Inc. (NYSE: A) by 6.2% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 221,291 shares of the medical research company's stock after purchasing an additional 12,997 shares during the quarter.
Bloomberg's 2026 Dividend Focus list highlights 16 'safer' stocks with free cash flow yields exceeding dividend yields, signaling strong dividend sustainability. Top projected net gains for 2026 include PT Telekom at 70.36%, with average net gain estimates of 28.13% across the top ten dividend-focused stocks. Five 'IDEAL' stocks—Continental, Aviva, PT Telekom, Danske Bank, and Western Midstream—offer dividends from $1,000 invested that exceed their single share price.
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly dividend will be paid on April 22, 2026, to all shareholders of record as of the close of business on March 31, 2026. The timing and amounts of future dividends are subject to the determination and approval of Agilent's board of directors. About Agilent Technologies Agilent Technologies, Inc. (NYSE: A) is a global leader in analyti.
SANTA CLARA, Calif.--(BUSINESS WIRE)-- #CircularEconomy--Agilent Technologies Inc. (NYSE: A) today announced that Boehringer Ingelheim has been selected as the winner of Agilent's inaugural Instrument Trade‑In Impact Award, recognizing exceptional sustainability leadership demonstrated through their participation in Agilent's trade‑in and buyback program. The annual award honors the global partner that achieves the highest sustainability impact by diverting end‑of‑life laboratory instruments from landfill and con.
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved PD-L1 IHC 22C3 pharmDx, Code SK006, as the only FDA-approved companion diagnostic indicated to aid in identifying first-line patients with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma (EOC), whose tumors express PD-L1 and who may be eligible for treatment with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy. PD-L1 IHC.
Envestnet Asset Management Inc. grew its stake in Agilent Technologies, Inc. (NYSE: A) by 3.8% in the undefined quarter, according to its most recent filing with the SEC. The firm owned 607,914 shares of the medical research company's stock after buying an additional 22,498 shares during the quarter. Envestnet Asset Management Inc. owned
Federated Hermes Inc. lessened its holdings in Agilent Technologies, Inc. (NYSE: A) by 82.7% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,128 shares of the medical research company's stock after selling 10,153 shares during the quarter. Federated Hermes Inc.'s
Investors seeking protection from geopolitical volatility and stubborn inflation in 2026 may find opportunity in short-term bonds, where active management has historically delivered returns 25% higher than passive strategies, according to Vontobel Asset Management. Research going back to the 1990s shows investors in short-term, high-quality corporate bonds typically earn total returns of 1.
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) announced today that it will present a range of next‑generation automated workflow innovations at the SLAS2026 International Conference & Exhibition, taking place February 7–11 in Boston, Massachusetts. Agilent will demonstrate how its expanding automation ecosystem—integrating advanced imaging, software, robotics, and AI‑powered optimization—supports laboratories in accelerating discovery with confidence, efficiency,.
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2026 after the stock market closes on Wednesday, Feb. 25. The company will host a conference call to discuss the results at 1:30 p.m. PST the same day. To join the listen-only conference call webcast, click the link on the Events section of Agilent's Investor Relations website. A recording of the call also will be available on the website for 90 days. Abo.